"10.1371_journal.pone.0053224","plos one","2012-12-27T00:00:00Z","Hisashi Urushihara; Masanori Taketsuna; Ying Liu; Eisei Oda; Masaki Nakamura; Shinichi Nishiuma; Rei Maeda","Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan; Asia-Pacific Statistical Sciences, Eli Lilly Japan K.K., Kobe, Hyogo, Japan; Global Patient Safety Japan, Eli Lilly Japan K.K., Kobe, Hyogo, Japan; Medical TOUKEI Corporation, Shinjuku-ku, Tokyo, Japan; Business Development Department, Medical Data Vision Co., Ltd., Chiyoda-ku, Tokyo, Japan","Conceived and designed the experiments: HU MT YL EO SN RM. Analyzed the data: EO MN. Wrote the paper: HU. Acquisition of data: MN. Interpreted the data: HU MT YL EO MN SN RM. Critical revision of the manuscript for important intellectual content: HU MT YL SN RM.","HU has served as a consultant to Eli Lilly Japan and received a research grant from Pfizer Health Research Foundation. MT, YL, SN, and RM are full-time employees of Eli Lilly Japan. EO is the President of Medical TOUKEI Corporation. MN is a full-time employee of Medical Data Vision Co., Ltd. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Hisashi Urushihara","HU",7,TRUE,6,NA,2,1,TRUE,FALSE,FALSE,0,NA,FALSE
